JPRN-UMIN000049997尚未招募Unknown
An observational study to evaluate the safety and efficacy of lenvatinib plus pembrolizumab combination therapy for advanced or recurrent uterine cancer after use of platinum-based drugs(GOGO-EM4) - GOGO-EM4
Gynecologic Oncology Group of Osaka(GOGO)0 个研究点目标入组 100 人开始时间: 2023年1月10日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Patients with recurrent endometrial cancer who have not received any chemotherapy, including platinum-based antineoplastic agents 2. Cases with obvious infection 3. Cases with active multiple cancers 4. Patients with persistent adverse events (Common Terminology Criteria for Adverse Events [CTCAE] version 5.0 Grade 2 or higher) from prior chemotherapy(Excluding epilation and peripheral neuropathy) 5. Cases with hematologic complications 6. Cases with a history of bone marrow transplantation 7. Cases with uncontrolled brain metastases 8. Patients with serious complications (cardiac disease, uncontrolled diabetes, malignant hypertension, bleeding tendency, etc.) 9. Pregnant or lactating patients and patients of childbearing potential (will) (except for patients using appropriate contraceptive methods) 10. Any other cases other than those listed above that the principal investigator deems inappropriate for enrollment of the case in the study.
研究者
相似试验
招募中
不适用
An observational study to evaluate the safety and efficacy of MegaDerm Soft in patients who underwent breast reconstruction using the MegaDerm soft.KCT0007432Soon Chun Hyang University Hospital Bucheon60
招募中
4 期
An observational study to evaluate the safety and efficacy of FOLFIRI / FOLFOX plus Cetuximab as first-line therapy inpatients with KRAS wild-type metastatic Colorectal cancerCTRI/2010/091/000161Merck Specialities Pvt Limited5th Floor , Shivsagar EstateDr. Annie Besant RoadMumbai 400018100
招募中
4 期
An Observational Study to evaluate the safety and efficacy of Cetuximab in combination with platinum-based chemotherapy, in the first-line therapy of recurrent/ metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)CTRI/2010/091/000170Merck Specialities Pvt Ltd5th Floor Shiv Sagar Estate, Dr. Aniie Besant Road, WorliMumbai 400018100
招募中
不适用
An observational study to investigate the safety and efficacy of niraparib for Japanese patients with recurrent ovarian cancer: maintenance therapy for platinum-sensitive recurrent treatment and monotherapy for late-line treatmentOvarian cancer, fallopian tube cancer, primary peritoneal cancerJPRN-UMIN000046970Japanese Gynecologic Oncology Group180
已完成
不适用
An observational study to investigate the safety and efficacy of niraparib maintenance therapy after primary chemotherapy for Japanese patients with advanced ovarian, fallopian tube, or primary peritoneal cancerovarian cancer, fallopian tube cancer, primary peritoneal cancerJPRN-UMIN000045931Japanese Gynecologic Oncology Group300